Inhibition of the Growth of a Panel of Pathogenic Bacteria by Kunzea

Inhibition of the Growth of a Panel of Pathogenic Bacteria by Kunzea

Pharmacogn. Commn. 2017; 7(3): 121-128 A multifaceted peer reviewed journal in the field of Pharmacognosy and Natural Products Original Article www.phcogcommn.org Inhibition of the Growth of a Panel of Pathogenic Bacteria by Kunzea flavescens C.T.White and W.D.Francis Solvent Extractions Getmore Rumbudzai Chikowe,a Lindiwe Nomathemba Mpala,a Ian Edwin Cocka,b* aSchool of Natural Sciences, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA. bEnvironmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA. ABSTRACT Introduction: Kunzea flavescens C.T.White & W.D.Francis is a shrub that P. mirabilis within 1 h of exposure. All extracts were determined to be is native to eastern Australia. Several Kunzea spp. have been used as tradi- nontoxic in the Artemia franciscana nauplii bioassay, indicating their tional medicines against bacterial pathogens. Despite this, K. flavescens safety for internal use as well as for topical uses. Conclusions: The lack leaf extractions have not been rigorously examined for growth inhibitory of toxicity of the K. flavescens leaf extracts and their growth inhibitory properties against many bacterial pathogens. Methods: The antimicrobial bioactivity against a panel of pathogenic bacteria indicate their potential in activity of K. flavescens leaf solvent extractions was investigated by disc the development of novel antiseptic agents. diffusion and growth time course assays against a panel of pathogenic Key words: Kunzea flavescens, Myrtaceae, Autoimmune inflammatory bacteria. The growth inhibitory activity was quantified by MIC determination. disease, Rheumatoid arthritis, Ankylosing spondylitis, Terpenoid, Antibacte- Toxicity was determined using the Artemia franciscana nauplii bioassay. rial activity, Medicinal plants. Results: Methanolic, aqueous and ethyl acetate K. flavescens leaf extracts inhibited the growth of a wide range of bacterial species. Growth of both gram positive and gram negative bacteria was inhibited by the K. flavescens Correspondence: leaf extracts, although a higher proportion of gram positive species were Ian Edwin Cock susceptible. The methanolic extract was generally more potent than the Environmental Futures Research Institute, aqueous or ethyl acetate extracts against all susceptible bacteria. The Griffith University, 170 Kessels Rd,Nathan, methanolic K. flavescens leaf extract was a particularly potent inhibitor of Brisbane, Queensland 4111, AUSTRALIA. P. mirabilis and K. pneumoniae growth, with MIC values of 393 and 481 µg/mL Tel.: +61 7 37357637; respectively. The antibacterial activity of the methanolic K. flavescens Fax: +61 7 37355282; leaf extract was further investigated by growth time course assays which E-mail: [email protected] (I. E. Cock) showed significant growth inhibition in cultures ofK. pneumoniae and DOI: 10.5530/pc.2017.3.18. INTRODUCTION Plants produce a wide variety of secondary metabolites which provide reported to inhibit bacterial growth.7, 9, 15, 16 However, most Kunzea spp. characteristic pigment, odour and flavour characteristics. In addition, are yet to be screened for bacterial growth inhibitory activity and much these compounds may also provide the plants with protection against work is required to examine the therapeutic potential of this genus. 1 microbial challenge. Traditional plant derived medicines have been Kunzea flavescens C.T.White & W.D.Francis (Figure 1a) is a small- used for thousands of years in most parts of the world and with the medium shrub which is native to eastern Australia, especially in south increase in microbial antibiotic resistance, their use in fighting bacterial east Queensland where it is usually found inhabiting rocky ridges in 2, 3 pathogens is becoming the focus of intense study. Whilst much of the heathland and in open woodland. The shrub grows 1-4 m tall with research into traditional medicinal plant use has focused on Asian4, crowded alternate, glabrous leaves which grow 4-8 mm long. White to African5 and South American6 plants, the therapeutic potential of the cream flowers (approximately 10-13 mm diameter) usually develop from flora of Australia has also been recognised for thousands of years. The September to November. Interestingly, we were unable to find confirmed first Australians had well developed ethnopharmacological systems reports of Aboriginal medicinal use of any part of K. flavescens although and understood the therapeutic properties of a wide variety of aromatic other Kunzea spp. have documented uses in treating skin diseases Australian plants.7 Despite this, relatively few studies have rigorously ex- including eczema, dermatitis and rashes.1,16 Many of these ailments are amined the antibacterial activity of Australian native plants, although there has been a recent increase in this field. caused by microbial pathogens. Oils prepared from several Kunzea spp. have also been reported to ease the pain of insect bites, minor burns, The healing properties of Australian plants of the family Myrtaceae headaches and inflammation.17 Despite this, antibacterial studies exam- have long been understood by Australian Aborigines. More recently, the ining the growth inhibitory properties of K. flavescens are lacking. bacterial growth inhibitory properties of many genera within the family Myrtaceae have been examined and documented. In particular, Callistemon Several interesting phytochemical components have been identified in spp.8, Eugenia spp.7, Kunzea spp.7,9, Leptospermum spp.7, 10, 11 and Syzygium Kunzea spp. extracts and essential oils. In particular, several terpenoid spp. 12-14 have been reported to inhibit the growth of a wide panel of components including α-pinene (Figure 1b), 1,8-cineole (Figure 1c), bacteria, including many medicinally important pathogens. The genus bicyclogermacrene (Figure 1d), spathulenjol (Figure 1e), globulol Kunzea (family Myrtaceae) consists of approximately 50 species of small (Figure 1f) and viridflorol (Figure 1g) have been identified in Kunzea to medium shrubs which are native to Australia, with 2 species also spp. extracts and essential oils.15,18 Interestingly, those studies also reported occurring in New Zealand. Perhaps the best known Kunzea spp. are broad spectrum antibacterial and anti-protozoal activity for the bark Kunzea ambigua (Sm.) Druce (commonly known as tick bush), Kunzea extracts and all of the isolated compounds. Indeed, the extract and ericoides (A.Rich) Joy Thomps. (commonly known as Kānuka, white isolated compounds inhibited the growth of all bacteria and protozoa tea-tree, Burgan) and Kunzea pomifera F.Muell. (commonly known as screened. Broad spectrum antifungal activity was also reported, albeit muntries, emu apples, native cranberries). These species have each been at doses which would indicate only moderate to low growth inhibitory Pharmacognosy Communications, Vol 7, Issue 3, Jul-Sep, 2017 121 Chikowe et al.:K. flavscens extracts inhibit bacterial growth through 0.22 µm filter (Sarstedt) and stored at 4 oC until use. Qualitative phytochemical studies Phytochemical analysis of the K. flavescens leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpe- noids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by previously described assays.19-21 Antibacterial screening Test microorganisms All media was supplied by Oxoid Ltd., Australia. Reference strains of Klebsiella pneumoniae (ATCC31488), Escherichia coli (ATCC 25922) and Proteus mirabilis (ATCC21721) were purchased from American Tissue Culture Collection, USA. Clinical isolate microbial strains of Aeromonas hydrophilia, Alcaligenes feacalis, Bacillus cereus, Citrobacter freundii, Pseudomonas fluorescens, Salmonella newport, Serratia marcescens, Shigella sonneii, Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus pyonenes were obtained from Ms Michelle Mendell and Ms Jane Gifkins, Griffith University. All stock cultures were subcultured and maintained in nutrient broth at 4oC. Evaluation of antimicrobial activity Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay.22-24 Briefly, 100 µL of each bacterial culture was grown in 10 mL of fresh nutrient broth until they reached a count of ~108 cells/mL. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar plates and extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of the plant extracts, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4 °C for 2 h before incubation at 30 °C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10 µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused Figure 1: K. flavescens (a) leaves and flowers as well as the chemical with 10 µL of distilled water were used as a negative control. structures of (b) α-pinene, (c) 1,8-cineole, (d) bicyclogermacrene, (e) spathulenjol, (f) globulol and (g) viridflorol. Minimum inhibitory concentration (MIC) determination The minimum inhibitory concentration (MIC) of each extract against susceptible bacteria was determined as previously described.25, 26 Briefly, activity. Despite these promising

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us